Alira Health

Alira Health
Contact us
Alira Health
Menu
Home > Education Hub > Webinar: RWE in Pharma: An Expert Panel Discussion

Webinar: RWE in Pharma: An Expert Panel Discussion

December 8, 2021 | 10:00 am ET

Events
Category:
Pharma
Published on:
November 21, 2021

Catia Proenca, PhD, Director, Global Market Access- RWE at Alira Health, will speak on an expert panel with other industry leads to discuss topics such as how RWE is important to understand the disease and the ease of generation. The panel will also investigate the challenges and developments facing RWE in light of COVID-19. All of this will be considered with a view towards the future, as the industry’s use of RWE continues evolving forward.

Register for the webinar here.

Related news

Case Studies March 20, 2025
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Patient Advocacy Patient Engagement Pharma
Case Studies March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity Pharma Rare Disease
Articles February 17, 2025
Rethinking Rare Disease Development: An Integrated, Patient Access-Driven Approach
Explore how biotech companies can succeed in rare disease by integrating development, commercialization, and patient access.
Patient Centricity Pharma Rare Disease
Articles February 11, 2025
From Diagnosis to Long-Term Care: Navigating the Rare Disease Journey
For Rare Disease Day, we spoke with patient engagement expert Luca Trentin on challenges faced by rare disease patients and how pharma can better understand their needs.
Patient Centricity Pharma Rare Disease
News January 8, 2025
Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London
Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona(...)
Health Policy Market Access Pharma
Articles December 10, 2024
2024 Antibody-Drug Conjugates Landscape: Market Expansion, Innovations, and Strategic Acquisitions
Antibody-Drug Conjugates (ADCs) have emerged as a groundbreaking strategy in precision oncology, uniquely merging the specificity of antibodies with the potency of cytotoxic drugs.
ADC Antibody-Drug Conjugates Pharma
News December 2, 2024
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market
This in-depth report explores emerging trends, competitive dynamics, market opportunities, cutting-edge innovations, and pivotal transactions shaping the antibody-drug conjugates (ADC) market.
ADC Antibody-Drug Conjugates Pharma
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.